Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fatma Abdelraouf"'
Publikováno v:
Egyptian Rheumatologist, Vol 44, Iss 2, Pp 121-125 (2022)
Background Inappropriate and excessive activation of type I interferon (IFN) system is a key feature of systemic lupus erythematosus (SLE), and its targeting has led to important achievements in the development of novel drugs for SLE. Aim of the work
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f626c16efcdc2db9fa954bd245b72cc
https://doi.org/10.1016/j.ejr.2021.10.004
https://doi.org/10.1016/j.ejr.2021.10.004
Publikováno v:
Archives of Reproductive Medicine and Sexual Health. 1:22-30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b7611decb7de0743228eb6e6d33130a
https://doi.org/10.22259/2639-1791.0101004
https://doi.org/10.22259/2639-1791.0101004
Publikováno v:
European Journal of Cancer. 60:26-39
Small cell lung cancer (SCLC) is a smoking-induced malignancy with multiple toxin-associated mutations, which accounts for 15% of all lung cancers. It remains a clinical challenge with a rapid doubling time, early dissemination and poor prognosis. De
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78b43cd60f7c09ec8b4e306727dbbfca
https://doi.org/10.1016/j.ejca.2016.03.004
https://doi.org/10.1016/j.ejca.2016.03.004
Autor:
Paul Baas, Veerle Surmont, Mary O'Brien, Jan P. van Meerbeeck, Fatma Abdelraouf, Jessica Menis, Sanjay Popat, Egbert F. Smit, Baktiar Hasan
Publikováno v:
Abdelraouf, F, Smit, E, Hasan, B, Menis, J, Popat, S, van Meerbeeck, J P, Surmont, V F, Baas, P & O'Brien, M 2016, ' Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061) ', European Journal of Cancer, vol. 54, pp. 35-39 . https://doi.org/10.1016/j.ejca.2015.10.016
European journal of cancer
European Journal of Cancer, 54, 35-39. Pergamon
European journal of cancer
European Journal of Cancer, 54, 35-39. Pergamon
Background Targeted therapies have to date not been successful in the treatment of small cell lung cancer (SCLC). This study aimed to assess the therapeutic activity of sunitinib (an oral, multi-targeted tyrosine kinase inhibitor) using positron emis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e7c29b6c704d8a644a5d09943f723c2
https://research.vumc.nl/en/publications/cad0bb25-6bae-4702-9283-5dda7a5b43ca
https://research.vumc.nl/en/publications/cad0bb25-6bae-4702-9283-5dda7a5b43ca
Autor:
Mary O'Brien, Jaishree Bhosle, Fatma Abdelraouf, A C Wotherspoon, Manisha Maurya, D. Mair, David Gonzalez de Castro, Sanjay Popat
Publikováno v:
Journal of Thoracic Oncology. (4):S7-S52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5dfeb62feca59f23c5db76699ad0891
Autor:
Alex Leary, Mary O'Brien, Jaishree Bhosle, D. Mair, Manisha Maurya, Sanjay Popat, Fatma Abdelraouf, Ayatallah Nassef, Andrew Wotherspoon, Adam Sharp, Taghrid Gaafar, David Gonzalez de Castro, Timothy A. Yap
Publikováno v:
BMC Research Notes
© 2015 Abdelraouf et al.Background: There is an urgent need to identify molecular signatures in small cell lung cancer (SCLC) that may select patients who are likely to respond to molecularly targeted therapies. In this study, we investigate the fea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96602920ef9cb1a482ed31639ef555d5